Corporate

Cellectis SA is a world leader in genome engineering. The company specializes in the development and production of meganucleases (DNA scissors) for in vivo genome surgery. Cellectis products are programmed to induce unique, site-directed, double-strand DNA breaks in a living cell and can be used for a wide range of therapeutic and biotechnological applications.